Real time electrophysiological testing of agents of interest for treatment of amyloid-type diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 17, 2013
Grant Date -
Dec 9, 2010
app pub date -
Oct 9, 2008
filing date -
Oct 9, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
This invention corresponds to an in vitro method that employs an electrophysiology technique; in particular, an embodiment of the patch-clamp technique in its perforated type, which will allow us evaluating the neurotoxic capacity of protein structures associated to the generation of neurodegenerative diseases. It addition, it allows evaluating potential pharmacologic capacities of candidate molecules (drugs) in order to prevent, treat, or cure the said diseases. The invention involves the use of peptides that cause neurodegenerative diseases in order to form a spontaneous perforated recording that only occurs with peptides in the patch clamp glass pipette.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully